First Header Logo Second Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Bonkovsky, Herbert
One or more keywords matched the following items that are connected to Bonkovsky, Herbert
Item TypeName
Concept Polyethylene Glycols
Academic Article Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
Academic Article Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.
Academic Article No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.
Academic Article Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
Academic Article HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
Academic Article Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
Academic Article Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
Academic Article Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Academic Article Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
Academic Article Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
Academic Article Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
Academic Article DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.
Academic Article Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.
Academic Article Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
Academic Article Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.
Academic Article Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
Academic Article Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Academic Article Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
Academic Article Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
Academic Article Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
Academic Article Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.
Academic Article Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
Academic Article Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
Academic Article Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
Academic Article Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
Academic Article Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
Academic Article Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
Academic Article A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
Academic Article YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.
Academic Article Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C.
Academic Article Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.
Search Criteria
  • Polyethylene Glycols